Revive Therapeutics Ltd (RVV)

Currency in CAD
0.020
-0.005(-20.00%)
Closed·
RVV is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0200.020
52 wk Range
0.0100.080
Key Statistics
Prev. Close
0.02
Open
0.02
Day's Range
0.02-0.02
52 wk Range
0.01-0.08
Volume
6.11K
Average Volume (3m)
20.13K
1-Year Change
33.3333%
Book Value / Share
-0.01
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RVV Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Revive Therapeutics Ltd News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Earnings

Latest Release
Jun 02, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

RVV Income Statement

Compare RVV to Peers and Sector

Metrics to compare
RVV
Peers
Sector
Relationship
P/E Ratio
−0.8x−4.0x−0.4x
PEG Ratio
0.010.000.00
Price/Book
−2.2x1.1x2.6x
Price / LTM Sales
-0.9x3.0x
Upside (Analyst Target)
-50.7%58.0%
Fair Value Upside
Unlock18.9%7.8%Unlock

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin, which is in Phase 1 clinical study for treating methamphetamine use disorder; and Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases. Revive Therapeutics Ltd. is based in Toronto, Canada.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
10.35K0.00%206.90
Public Companies & Retail Investors
436.49M100.00%8.73M
Total
436.5M100.00%8.73M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
FineMark National Bank & Trust0.00%10,3450

FAQ

What Is the Revive Therapeutics (RVV) Stock Price Today?

The Revive Therapeutics stock price today is 0.020 CAD.

What Stock Exchange Does Revive Therapeutics Trade On?

Revive Therapeutics is listed and trades on the CBOE Canada Exchange.

What Is the Stock Symbol for Revive Therapeutics?

The stock symbol for Revive Therapeutics is "RVV."

What Is the Revive Therapeutics Market Cap?

As of today, Revive Therapeutics market cap is 8.710M CAD.

What Is Revive Therapeutics's Earnings Per Share (TTM)?

The Revive Therapeutics EPS (TTM) is -0.025.

From a Technical Analysis Perspective, Is RVV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Revive Therapeutics Stock Split?

Revive Therapeutics has split 0 times.

How Many Employees Does Revive Therapeutics Have?

Revive Therapeutics has 2 employees.

What is the current trading status of Revive Therapeutics (RVV)?

As of Sep 27, 2026, Revive Therapeutics (RVV) is trading at a price of 0.020 CAD, with a previous close of 0.020 CAD. The stock has fluctuated within a day range of 0.020 CAD to 0.020 CAD, while its 52-week range spans from 0.010 CAD to 0.080 CAD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.